04785nam a22005775i 4500 978-981-97-3115-2 DE-He213 20251030112642.0 cr nn 008mamaa 240722s2024 si | s |||| 0|eng d 9789819731152 978-981-97-3115-2 10.1007/978-981-97-3115-2 doi RM300-666 MMG bicssc MED071000 bisacsh MKG thema Nanotheranostics for Diagnosis and Therapy [electronic resource] / edited by Md. Abul Barkat, Farhan Jalees Ahmad, Mohammad Akhlaquer Rahman, Mohammad Azam Ansari. 1st ed. 2024. Singapore : Springer Nature Singapore : Imprint: Springer, 2024. XV, 331 p. 46 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Chapter 1_Introduction to the nanofabrication for theranostics application -- Chapter 2_Nanotheranostics: a treasured tailor for disease diagnosis and treatment -- Chapter 3_Theranostics as a novel strategy for targeted delivery of therapeutics: Transport and fate mechanism, challenge, and opportunities -- Chapter 4_Nanotheranostics, a potential diagnostic tool in the cancer management: befriending the barriers -- Chapter 5_Bio-inspired nanomaterials in cancer theranostics -- Chapter 6_Stratagems for Breast Cancer Management in the Era of NanoTheranostics -- Chapter 7_Nanoscale theranostics for Hepatocellular Carcinoma -- Chapter 8_Progress and Prospect of Nanocarriers: Design, Concept and Recent Advances -- Chapter 9_Theranostic application of nanomedicine in neurodegenerative diseases: current and future perspectives -- Chapter 10_Nanotheranostics: clinical status, toxicity, regulatory consideration, and future prospects -- Chapter 11_Nanotheranostics in prostate cancer: Current status and future potential -- Chapter 12_Theranostics as an emerging integrated imaging and therapies in Precision Oncology. This book provides an updated account of recent advancements in the field of nanotechnology-based theranostics with special emphasis on their application in the diagnosis and treatment of various types of cancer and neurological diseases. The book is divided into two sections; the first section provides an introduction to the nanoscale theranostics & radiopharmaceuticals. The second section highlights the importance of nanoscale theranostics in disease diagnosis & treatment. It presents the potential of nanotechnology for developing nanomedicine and nanotheranostics for the diagnosis and treatment of a variety of illnesses. Further, the book discusses the usefulness of theranostic nanoparticles in the diagnosis of disease, identification of location, and stage, and in providing information about the therapy response. In addition, the book focuses on the clinical applications of nanomaterial radiolabeling in nuclear imaging of cancer and other illness. Towards the end, the bookexamines the toxicity, regulatory protocols, and future aspects of clinical applications of theranostics. This book is an invaluable source for academicians and industrial scientists working in multiple healthcare fields like pharmaceutical and biological sciences, life sciences, biotechnology, biomedical engineering, and nanobiotechnology. Pharmacology. 67844 Nervous system Diseases. 64036 Cancer. 4311 Nanobiotechnology. 67632 Pharmacology. 67844 Neurological Disorders. 74042 Cancers. 71203 Nanobiotechnology. 67632 Barkat, Md. Abul. editor. edt http://id.loc.gov/vocabulary/relators/edt 81023 Ahmad, Farhan Jalees. editor. edt http://id.loc.gov/vocabulary/relators/edt 79866 Rahman, Mohammad Akhlaquer. editor. edt http://id.loc.gov/vocabulary/relators/edt 81024 Ansari, Mohammad Azam. editor. (orcid)0000-0002-6122-5479 https://orcid.org/0000-0002-6122-5479 edt http://id.loc.gov/vocabulary/relators/edt 81025 SpringerLink (Online service) Springer Nature eBook Printed edition: 9789819731145 Printed edition: 9789819731169 Printed edition: 9789819731176 https://doi.org/10.1007/978-981-97-3115-2 ZDB-2-SBL ZDB-2-SXB 61807 61807